- Home
- MTLS vs ITOS Comparison
MTLS vs ITOS Comparison
Compare MTLS & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTLS
- ITOS
- Stock Information
- Founded
- MTLS 1990
- ITOS 2011
- Country
- MTLS Belgium
- ITOS United States
- Employees
- MTLS N/A
- ITOS N/A
- Industry
- MTLS Computer Software: Prepackaged Software
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MTLS Technology
- ITOS Health Care
- Exchange
- MTLS Nasdaq
- ITOS Nasdaq
- Market Cap
- MTLS 297.1M
- ITOS 270.7M
- IPO Year
- MTLS 2014
- ITOS 2020
- Fundamental
- Price
- MTLS $5.24
- ITOS $7.32
- Analyst Decision
- MTLS Buy
- ITOS Strong Buy
- Analyst Count
- MTLS 1
- ITOS 3
- Target Price
- MTLS $9.50
- ITOS $26.00
- AVG Volume (30 Days)
- MTLS 521.2K
- ITOS 370.8K
- Earning Date
- MTLS 04-24-2025
- ITOS 03-05-2025
- Dividend Yield
- MTLS N/A
- ITOS N/A
- EPS Growth
- MTLS 106.79
- ITOS N/A
- EPS
- MTLS 0.24
- ITOS N/A
- Revenue
- MTLS $276,182,835.00
- ITOS $35,000,000.00
- Revenue This Year
- MTLS $6.55
- ITOS N/A
- Revenue Next Year
- MTLS $9.21
- ITOS $121.70
- P/E Ratio
- MTLS $22.23
- ITOS N/A
- Revenue Growth
- MTLS 4.15
- ITOS 177.89
- 52 Week Low
- MTLS $4.70
- ITOS $6.67
- 52 Week High
- MTLS $9.69
- ITOS $18.75
- Technical
- Relative Strength Index (RSI)
- MTLS 34.03
- ITOS 50.93
- Support Level
- MTLS $4.87
- ITOS $6.73
- Resistance Level
- MTLS $5.13
- ITOS $7.65
- Average True Range (ATR)
- MTLS 0.24
- ITOS 0.39
- MACD
- MTLS 0.01
- ITOS 0.04
- Stochastic Oscillator
- MTLS 30.17
- ITOS 66.33
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, Poland, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.